Daily Round Up 10/13/16: Ruby Tuesday, Vishay Precision, Argos Therapeutics, Star Gold

by: InsiderInsights


Tables of the top insider purchases and sales filed with the SEC on 10/13/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

Educational note from InsiderInsights:

Insider filing volumes are at a seasonal low point due to companies closing trading windows to their insiders until quarterly earnings are released. As a result, the dollar values of trades featured in our Daily Round Up articles (particularly the purchases) will likely be lower than usual through October.

On Today's Tables:

Insider trades were rated Significant at:

  • Vishay Precision (NYSE:VPG);
  • Star Gold (OTCQB:SRGZ);
  • Ruby Tuesday (NYSE:RT), and;
  • Argos Therapeutics (NASDAQ:ARGS).

Insider trades were considered Insignificant at:

  • Mercer Intl (NASDAQ:MERC);
  • Actuant (NYSE:ATU);
  • Veeva Systems (NYSE:VEEV);
  • Stryker (NYSE:SYK);
  • Q2 (NYSE:QTWO);
  • Penn West Petroleum (NYSE:PWE);
  • Occidental Petroleum (NYSE:OXY);
  • Interdigital (NASDAQ:IDCC);
  • Foot Locker (NYSE:FL), and;
  • Curtiss Wright (NYSE:CW).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Usana Health (NYSE:USNA), and;
  • Mindbody (NASDAQ:MB).

There is an IPO or Known Corporate Action at:

  • Aquaventure Holdings (NYSE:WAAS), and;
  • Coupa Software (NASDAQ:COUP).

It's difficult to argue significance for most transactions made during IPOs, or when insiders make trades during a known corporate action.

Insider Purchases

#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Abdiel Capital Mgt BO Mindbody MB B $9,110,000
2 Battery Ventures VIII BO Coupa Software COUP JB* $4,950,000
3 Muller Lee S CFO Aquaventure Holdings WAAS JB* $1,260,000
4 Kellogg Peter R BO Mercer Intl MERC B $633,337
5 Nokomis Capital BO Vishay Precision VPG B $411,908
6 Hess Donald E DIR Ruby Tuesday RT B $325,354
7 Ibarguen Anthony PR,DIR Aquaventure Holdings WAAS JB* $225,900
8 Baker Randal W CEO,DIR Actuant ATU B $225,500
9 Gorrill Lindsay Edward DIR,BO,DIR Star Gold SRGZ JB* $186,700
10 Pharmstandard Intl BO Argos Therapeutics ARGS B $149,993
Click to enlarge

Source: | Key to Insider Title and Trans Type Codes :
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales

#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Ho Cheuk Fund FO Penn West Petroleum PWE S $3,410,285
2 Adams David Charles CB,CEO Curtiss Wright CW S $2,213,000
3 Gull Global BO Usana Health USNA AS $1,463,495
4 Stryker Ronda E DIR Stryker SYK AS $1,360,876
5 Jonas Howard S CB,DIR,BO IDT IDT AS $735,859
6 Seale R H DIR,BO Q2 QTWO AS $703,250
7 Turpin Cheryl N DIR Foot Locker FL S $691,590
8 Chazen Stephen I DIR Occidental Petroleum OXY AS $664,162
9 Sekhri Paul J DIR Veeva Systems VEEV AS $663,714
10 Roath Robert S DIR Interdigital IDCC AS $533,723
Click to enlarge | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.